Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Integrated Oncology ...

The transaction, subject to regulatory approval, is expected to close later this year, a Cardinal spokesperson said.

The 39th AROI conference at CMC Vellore focused on advancements in radiation oncology with a green initiative.

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

Growing momentum in research sets China up as a formidable player in future of global healthcare, according to scientific ...

AVEO Oncology, an LG Chem company ("AVEO"), announced today that the TiNivo-2 Phase 3 clinical trial results in patients with ...

The European Society for Medical Oncology (ESMO) is calling on all actors of the oncology community to commit to improving the well-being of the cancer workforce and join in 11 actions outlined in a ...

We recently published a list of Jim Cramer’s Must-Watch List: 10 Stocks to Look After. In this article, we are going to take ...

Adela’s tissue-agnostic MRD test has been clinically validated to predict and surveil for recurrence in patients with head & ...

Bispecific antibodies and anti-TIGIT therapies both appear to be writing comeback stories as cancer experts head to Barcelona for the 2024 European Society for Medical Oncology Congress. Radioligand ...